Skip to main content

Peer Review reports

From: Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study

Original Submission
25 Aug 2020 Submitted Original manuscript
15 Nov 2020 Author responded Author comments - Chunlong Huang
12 Sep 2020 Reviewed Reviewer Report
26 Sep 2020 Reviewed Reviewer Report
9 Oct 2020 Reviewed Reviewer Report
Resubmission - Version 2
15 Nov 2020 Submitted Manuscript version 2
18 Dec 2020 Author responded Author comments - Chunlong Huang
21 Nov 2020 Reviewed Reviewer Report
15 Dec 2020 Reviewed Reviewer Report
22 Nov 2020 Reviewed Reviewer Report
Resubmission - Version 3
18 Dec 2020 Submitted Manuscript version 3
Publishing
26 Dec 2020 Editorially accepted
7 Jan 2021 Article published 10.1186/s12885-020-07770-9

You can find further information about peer review here.

Back to article page